PRN 1008

• Description:

  PRN1008 is a novel reversible, covalent and oral inhibitor of BTK with biochemical IC50 of 1.3 nM.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  665.774

• Molecular Formula:

  C36H40FN9O3

• Notes:

  Research use only, not for human use.

• Receptor:

  BTK

• CAS Number:

  1575596-29-0